Doctors evaluate the benefits of weight loss surgery compared to GLP-1 medication choices.

With the rising trend of GLP-1 weight loss medications, there have been concerns about whether surgical options like lap bands, gastric sleeves, and bypass surgeries will become less popular. Carney Wilson, a member of the band Wilson Phillips, recently opened up about her daunting experience on social media regarding the removal of her laparoscopic lap […]
GLP-1 medications associated with reduced cancer risk, especially in women, according to recent research.

Expanding Benefits of GLP-1 Drugs New research highlights the expanding potential of GLP-1 drugs, which are officially classified as glucagon-like peptide 1 receptor agonists. Notably, these medications may be linked to a reduced risk of cancer among some women. Researchers from Indiana University and the University of Florida investigated the occurrences of 14 types of […]
Weight-loss physician explains how GLP-1 medications also address chronic illness

Recent research indicates that weight loss and diabetes medications, known as glucagon-like peptide-1 receptor agonists (GLP-1), could be beneficial for a range of other health issues. These issues include cardiovascular disease, arthritis, skin conditions, and potentially even cancer prevention. The use of these drugs is linked to a reduced risk of chronic diseases, with a […]
GLP-1 drugs may reduce death rates in the US by 6.4%, new research shows.

GLP-1 Weight Loss Drug Development Dr. Marc Siegel, a senior medical analyst, recently discussed developments in weight loss drugs, the safety of nicotine patches, and shared insights from an interview with FDA Commissioner Dr. Marty Makary. A recent study suggests that drugs for diabetes and weight loss could lead to significant reductions in mortality rates […]
Medicare needs to include GLP-1 medications for obesity treatment

In the United States, obesity has become increasingly common and impactful, yet it took over four decades before bariatric surgery was included as a covered treatment under Medicare. This delay meant that countless Americans suffered and even died from conditions related to obesity while waiting for access to crucial care. Let’s not allow history to […]
Doctor recommends daily use of GLP-1 medications for best health.

GLP-1 drugs like Ozempic and Wegovi are gaining attention not only for their effectiveness in managing diabetes and aiding weight loss but also for their expanding health benefits. Interestingly, some medical professionals, such as Dr. Terry Dubrow, a plastic surgeon and TV personality from Newport Beach, California, suggest that even individuals who don’t wish to […]
Microbeads that block fat may compete with GLP-1 medications for weight loss, according to a study

Recent studies suggest that microbeads composed of green tea, vitamin E, and seaweed could provide new avenues for weight loss, potentially offering alternatives to GLP-1 drugs and bariatric surgery. While human testing is still needed, researchers in China observed that rats on high-fat diets lost approximately 17% of their body weight when they consumed these […]
GLP-1 medications such as Ozempic and Wegovy might turn into the next all-encompassing solution.

GLP-1 Weight Loss Drug in Development Dr. Marc Siegel, a senior medical analyst, discussed recent advances in weight loss drugs, safety issues with nicotine patches, and trends in vaccine protocols during an interview with FDA Commissioner Dr. Marty Makary. GLP-1 agonists like Ozempic, Wegovy, Munjaro, and Zepbound were initially designed to manage type 2 diabetes […]
GLP-1 medications such as Ozempic are changing how Americans eat and impacting the restaurant business.

NYC Restaurant Serves “GLP-1 Meal” Max Tucci, a media personality and restaurateur, has shared how his New York City eatery, Tucci, is catering to users of weight loss medications, specifically those using GLP-1 drugs like Ozempic. This trend was discussed on “Fox & Friends Weekend.” Medical experts indicate that drugs like Ozempic are not only […]
Rising employer health care costs in 2026 are influenced by GLP-1 drugs and cancer treatment.

Experts suggest that companies are likely to respond to rising costs by intensifying their scrutiny of health insurers and other vendors, aiming to find cost-effective alternatives. Ellen Kelsay, CEO of the Health Business Group, mentioned that while businesses want to protect their employees as much as possible, rising costs might lead to higher premiums and […]